|
|
|
|
| LEADER |
02604nam a22002895i 4500 |
| 001 |
000285037 |
| 005 |
20210525143949.0 |
| 007 |
cr nn 008mamaa |
| 008 |
110930s2012 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781617793370
|
| 024 |
7 |
|
|a 10.1007/978-1-61779-337-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Kinase Inhibitors :
|b Methods and Protocols /
|c edited by Bernhard Kuster.
|
| 250 |
|
|
|a 1st ed. 2012.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2012.
|
| 300 |
|
|
|a XI, 256 p. 47 illus., 11 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 795
|
| 505 |
0 |
|
|a Targeting Cancer with Small Molecular Weight Kinase Inhibitors -- Small Molecule Protein and Lipid Kinase Inhibitors in Inflammation and Specific Models for their Evaluation -- Measuring the Activity of Leucine Rich Repeat Kinase 2 (LRRK2) – A Kinase Involved in Parkinson’s Disease -- Measuring PI3K Lipid Kinase Activity -- A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-box Domain of Polo-like Kinase 1 -- Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology -- Kinase Inhibitor Selectivity Profiling using Differential Scanning Fluorimetry -- Chemoproteomic Characterization of Protein Kinase Inhibitors using Immobilized ATP -- Proteome-wide identification of staurosporine-binding kinases using Capture Compound Mass Spectrometry -- Affinity Purification of Proteins Binding to Kinase Inhibitors Immobilised on Self Assembling Monolayers -- Kinase Inhibitor Profiling using Chemoproteomics -- Covalent Crosslinking of Kinases with Their Corresponding Peptide Substrates -- Receptor Tyrosine Kinase Inhibitor Profiling using Bead-based Multiplex Sandwich Immunoassays -- Monitoring Phosphoproteomic Response To Targeted Kinase Inhibitors Using Reverse-Phase Protein Microarrays -- Measuring Phosphorylation Specific Changes in Response to Kinase Inhibitors in Mammalian Cells Using Quantitative Proteomics -- Investigation of Acquired Resistance to EGFR-Targeted Therapies in Lung Cancer Using cDNA Microarrays.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
|
|a Kuster, Bernhard.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|